193 related articles for article (PubMed ID: 32774471)
1. Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes.
Saif-Ali R; Kamaruddin NA; Al-Habori M; Al-Dubai SA; Ngah WZW
Diabetol Metab Syndr; 2020; 12():67. PubMed ID: 32774471
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Metabolic Syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and Modified World Health Organization Definitions.
Bee YT; Haresh KK; Rajibans S
Malays J Nutr; 2008 Mar; 14(1):65-77. PubMed ID: 22691765
[TBL] [Abstract][Full Text] [Related]
3. Evolution of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus Asian-Indian Patients Over the Last 15 Years using Adult Treatment Panel III of the National Cholesterol Education Program, World Health Organization, and International Diabetes Federation Criterion.
Tuteja HS; Nassikar N; Panikar K; Tiwaskar M; Walwalkar S; Sachdev I; Kamble S; Kadir P; Mahajan A; Joshi S; Panikar V
J Assoc Physicians India; 2024 Jun; 72(6):39-43. PubMed ID: 38881133
[TBL] [Abstract][Full Text] [Related]
4. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
Sirdah MM; Abu Ghali AS; Al Laham NA
Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of metabolic syndrome among adults in freetown, Sierra Leone: A comparative analysis of NCEP ATP III, IDF and harmonized ATP III criteria.
Russell JBW; Koroma TR; Sesay S; Samura SK; Lakoh S; Bockarie A; Abiri OA; Conteh V; Conteh S; Smith M; Mahdi OZ; Lisk DR
Int J Cardiol Cardiovasc Risk Prev; 2024 Mar; 20():200236. PubMed ID: 38299125
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of undiagnosed metabolic syndrome using three different definitions and identifying associated risk factors among apparently healthy adults in Karachi, Pakistan: a cross-sectional survey in the year 2022.
Adil SO; Musa KI; Uddin F; Khan A; Khan I; Shakeel A; Shafique K; Islam MA
Arch Public Health; 2024 Feb; 82(1):22. PubMed ID: 38378657
[TBL] [Abstract][Full Text] [Related]
8. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
[TBL] [Abstract][Full Text] [Related]
9. Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study.
Yousefzadeh G; Sayyadi A; Najafipour H; Sabaghnejad V; Pezeshki S
Endocrinol Diabetes Metab; 2024 Jan; 7(1):e468. PubMed ID: 38268305
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria.
Pokharel DR; Khadka D; Sigdel M; Yadav NK; Acharya S; Kafle RC; Shukla PS
J Diabetes Metab Disord; 2014; 13(1):104. PubMed ID: 25469328
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program.
Yayıcı Köken Ö; Kara C; Can Yılmaz G; Aydın HM
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):55-62. PubMed ID: 31434460
[TBL] [Abstract][Full Text] [Related]
12. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
13. The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur.
Moy FM; Bulgiba A
BMC Public Health; 2010 Nov; 10():678. PubMed ID: 21054885
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Metabolic Syndrome among Korean Adolescents According to the National Cholesterol Education Program, Adult Treatment Panel III and International Diabetes Federation.
Kim S; So WY
Nutrients; 2016 Oct; 8(10):. PubMed ID: 27706073
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions.
Herath HMM; Weerasinghe NP; Weerarathna TP; Amarathunga A
Int J Chronic Dis; 2018; 2018():7813537. PubMed ID: 30175110
[TBL] [Abstract][Full Text] [Related]
16. Which Criteria to Use to Identify Metabolic Syndrome among Patients with Addictive Disorders?: Observations among Patients with Alcohol and Opioid Dependence Syndrome.
Singh Balhara YP; Jain R; Kuppili PP; Shukla A; Chawla N; Gupta R
Indian J Endocrinol Metab; 2018; 22(4):565-568. PubMed ID: 30148108
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain].
Rodríguez Bernardino A; García Polavieja P; Reviriego Fernández J; Serrano Ríos M
Endocrinol Nutr; 2010 Feb; 57(2):60-70. PubMed ID: 20153706
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome and the comparison of fasting plasma glucose and HbA1c as the glycemic criterion for MetS definition in non-diabetic population in Ghana.
Annani-Akollor ME; Laing EF; Osei H; Mensah E; Owiredu EW; Afranie BO; Anto EO
Diabetol Metab Syndr; 2019; 11():26. PubMed ID: 30949244
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
